Literature DB >> 15714178

Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system.

Noush Afarin Farasati1, Ron Shapiro, Abhay Vats, Parmjeet Randhawa.   

Abstract

BACKGROUND: Cidofovir and Leflunomide are used empirically in the treatment of BK virus nephropathy. The aim of this study is to quantify the antiviral activity of these drugs.
METHODS: BK virus was grown in a cell-culture system. The rate of viral replication in the presence or absence of the drug being tested was assessed using a quantitative polymerase chain reaction assay.
RESULTS: The inhibitory concentration, effective concentration, and selectivity index for Leflunomide are 39.7+/-6.9, 11.3+/-2.8, and 3.8+/-0.8 microg/mL, respectively. For Cidofovir, these indices were, respectively, 63.9+/-17.2, 36.3+/-11.7, and 2.3+/-0.8 microg/mL.
CONCLUSIONS: The in vitro activity of Cidofovir and Leflunomide is modest, and the selectivity index is low. There is a need to develop more effective and less toxic anti-BK virus drugs for clinical use.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15714178     DOI: 10.1097/01.tp.0000149338.97084.5f

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  37 in total

Review 1.  BK polyomavirus: emerging pathogen.

Authors:  Shauna M Bennett; Nicole M Broekema; Michael J Imperiale
Journal:  Microbes Infect       Date:  2012-02-24       Impact factor: 2.700

Review 2.  Immunotherapy for De Novo renal transplantation: what's in the pipeline?

Authors:  Helio Tedesco Silva; Paula Pinheiro Machado; Claudia Rosso Felipe; Jose Osmar Medina Pestana
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  Polyomavirus BK infection in blood and marrow transplant recipients.

Authors:  L K Dropulic; R J Jones
Journal:  Bone Marrow Transplant       Date:  2007-10-22       Impact factor: 5.483

Review 4.  Immunosuppressive drug therapy.

Authors:  Choli Hartono; Thangamani Muthukumar; Manikkam Suthanthiran
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

5.  Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.

Authors:  Thurid Ahlenstiel-Grunow; Lars Pape
Journal:  Pediatr Nephrol       Date:  2018-12-11       Impact factor: 3.714

6.  Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV).

Authors:  Aurelio Bonavia; Michael Franti; Erin Pusateri Keaney; Kelli Kuhen; Mohindra Seepersaud; Branko Radetich; Jian Shao; Ayako Honda; Janetta Dewhurst; Kara Balabanis; James Monroe; Karen Wolff; Colin Osborne; Leanne Lanieri; Keith Hoffmaster; Jakal Amin; Judit Markovits; Michelle Broome; Elizabeth Skuba; Ivan Cornella-Taracido; Gerard Joberty; Tewis Bouwmeester; Lawrence Hamann; John A Tallarico; Ruben Tommasi; Teresa Compton; Simon M Bushell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

7.  Determination of cidofovir in human plasma after low dose drug administration using high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Jeremiah D Momper; Shimin Zhang; Parmjeet S Randhawa; Ron Shapiro; Kristine S Schonder; Raman Venkataramanan
Journal:  J Pharm Biomed Anal       Date:  2010-07-06       Impact factor: 3.935

8.  Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.

Authors:  Yijin Wang; Wenshi Wang; Lei Xu; Xinying Zhou; Ehsan Shokrollahi; Krzysztof Felczak; Luc J W van der Laan; Krzysztof W Pankiewicz; Dave Sprengers; Nicolaas J H Raat; Herold J Metselaar; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

9.  Leflunomide inhibition of BK virus replication in renal tubular epithelial cells.

Authors:  Eva Bernhoff; Garth D Tylden; Lars J Kjerpeseth; Tore J Gutteberg; Hans H Hirsch; Christine H Rinaldo
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

10.  Anti-BK virus activity of nucleoside analogs.

Authors:  Parmjeet Randhawa; Jiri Zemlicka; Andreas Sauerbrei; Chris Meier; Karl Y Hostetler; James R Beadle; Noush Afarin Farasati; Yuchen Huang; Matthews Bradley
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.